Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial

Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial

<p>Synopsis</p> <p>Background</p> <p>Direct myocardial cell protection in patients with unstable angina or evolving myocardial infarction (MI) could prevent cell necrosis or reduce its extent, and minimize the risk of MI and death associated with percutaneous coronary i...

Full description

Bibliographic Details
Main Authors: Schroeder John S, Nickel Wolf-Ulrich, Meinertz Thomas, Jessel Andreas, Erhardt Leif, Chaitman Bernard R, Theroux Pierre, Tognoni Gianni, White Harvey, Willerson James T
Format: Article
Language:English
Published: BMC 2000-08-01
Series:Current Controlled Trials in Cardiovascular Medicine
Subjects:
cariporide
coronary angioplasty
coronary artery bypass graft surgery
myocardial cell protection
sodium/hydrogen exchanger
Online Access:http://cvm.controlled-trials.com/content/1/1/059

Internet

http://cvm.controlled-trials.com/content/1/1/059

Similar Items